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Efficacy of Barium-Based Fecal Tagging
for CT Colonography: a Comparison
between the Use of High and Low Density
Barium Suspensions in a Korean
Population - - a Preliminary Study
Objective: This preliminarily study was designed to determine and to compare
the efficacy of two commercially available barium-based fecal tagging agents for
CT colonography (CTC) (high-density [40% w/v] and low-density [4.6% w/v] bari-
um suspensions) in a population in Korea.
Materials and Methods: In a population with an identified with an average-risk
for colorectal cancer, 15 adults were administered three doses of 20 ml 40% w/v
barium for fecal tagging (group I) and 15 adults were administered three doses of
200 ml 4.6% w/v barium (group II) for fecal tagging. Excluding five patients in
group I and one patient in group II that left the study, ten patients in group I and
14 patients in group II were finally included in the analysis. Two experienced
readers evaluated the CTC images in consensus regarding the degree of tagging
of stool pieces 6 mm or larger. Stool pieces were confirmed with the use of stan-
dardized CTC criteria or the absence of matched lesions as seen on
colonoscopy. The rates of complete fecal tagging were analyzed on a per-lesion
and a per-segment basis and were compared between the patients in the two
groups.
Results: Per-lesion rates of complete fecal tagging were 52% (22 of 42; 95%
CI, 37.7-66.6%) in group I and 78% (28 of 36; 95% CI, 61.7-88.5%) in group II.
The difference between the two groups did not reach statistical significance (p =
0.285). The per-segment rates of complete tagging were 33% (6 of 18; 95% CI,
16.1%-56.4%) in group I and 60% (9 of 15; 95% CI, 35.7%-80.3%) in group II;
again, the difference between the two groups did not reach statistical significance
(p = 0.171).
Conclusion: Barium-based fecal tagging using both the 40% w/v and the 4.6%
w/v barium suspensions showed moderate tagging efficacy. The preliminary
comparison did not demonstrate a statistically significant difference in the tagging
efficacy between the use of the two tagging agents, despite the tendency toward
better tagging with the use of the 4.6% w/v barium suspension.
ecal tagging is labeling of fecal residue in the colon by oral ingestion of a
small amount of positive contrast material as part of the preparation prior
to CT colonography (CTC) (1). The use of fecal tagging improves the
differentiation of residual feces from polyps and thereby false-positives can be
avoided. Fecal tagging also offers the opportunity to reduce the extent of cathartic
cleansing for CTC and therefore can improve patient compliance (2). Reduction of the
discomfort of purgative bowel cleansing before CTC is a substantial advantage for
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Fpatients as studies have shown that bowel cleansing
represented the most unpleasant part of colonic examina-
tions (3, 4). Given the importance, fecal tagging is
becoming widely accepted as a standard procedure for
CTC.
Different tagging methods, including various densities of
barium, water-soluble iodinated contrast agents and
combinations have been previously evaluated (2, 5-14). Of
these methods, barium-based fecal tagging (2) has been
particularly widely adopted due to cost-effectiveness,
safety and commercial availability. Most studies regarding
the effectiveness of fecal tagging and optimal tagging
methods have been performed in Western populations
with Western diets. However, the effectiveness of fecal
tagging and optimal tagging methods may possibly vary
according to the dietary habits of different ethnic groups.
To the best of our knowledge, there have been no
published studies about the efficacy of fecal tagging or
optimal fecal tagging methods in a population from South
Korea, even though commercial fecal tagging agents are
already available in South Korea. There have been a few
clinical studies with CTC conducted in Korean patients
where fecal tagging was used in a subgroup of the patients;
however, the efficacy of fecal tagging was not specifically
addressed in the studies (15, 16).
The purpose of this preliminary study was to determine
and to compare the efficacy of two commercially available
barium-based fecal tagging agents for CTC (high-density
[40% w/v] and low-density [4.6% w/v] barium suspen-
sions) in a population from Korea by using the rate of
complete fecal tagging as the primary outcome measure.
MATERIALS AND METHODS
The institutional review board approved this study and
informed consent was obtained from all of the participants.
Study Patients
From March 2006 to July 2006, 30 asymptomatic adults
with an average-risk for colorectal cancer were recruited
for this study. The participants were selected from subjects
who were scheduled for colorectal screening at our institu-
tion. Subjects were excluded who had undergone colorec-
tal imaging (including sigmoidoscopy, colonoscopy, CTC
or a barium enema) within the prior five years, subjects
with a history of colorectal disease or surgery, subjects
with symptoms of lower gastrointestinal tract disease and
subjects with a first-degree relative that was diagnosed
with colorectal cancer. The first set of 15 patients (group I)
were assigned to undergo fecal tagging with use of a 40%
w/v barium suspension (Tagitol V; E-Z-EM, Westbury,
NY). The second set of 15 patients (group II) were assigned
were assigned to undergo fecal tagging with use of a 4.6%
w/v barium suspension (Easy CT 4.6; Taejoon
Pharmaceuticals, Seoul, Korea).
Bowel Preparation and Fecal Tagging
Bowel preparation for CTC started two days before the
examination. The patients were requested to refrain from
foods that were rich in fiber (such as pickled or fermented
cabbage or radishes, e.g. kimchi (17), bean sprouts, lettuce
or garlic), seeded fruits (such as grapes, watermelon or
other types of melon) and seaweed. The day before the
CTC examination, the patients were instructed to eat rice
porridge at breakfast, lunch, and dinner, with the ingestion
of the barium suspensions at the end of each meal. For the
group I patients, three doses (each dose at the end of each
meal) of 20 mL 40% w/v barium suspension were adminis-
tered. For the group II patients, three doses of 200 mL
4.6% w/v barium suspension were administered. Each
tagging protocol resulted in a total barium load of 24 g and
27.6 g in group I and group II patients, respectively.
Colonic purgation was performed using the same protocol
in both group I and group II patients in the evening prior to
the CTC examination by the administration of 19.2 g
magnesium citrate in the form of a 250 mL solution
(Magcorol Solution; Taejoon Pharmaceuticals) and 20 mg
of bisacodyl (Dulcolax; Boehringer Ingelheim, Seoul,
Korea).
CT Colonography Scanning
A small catheter with a retention cuff (PROTOCO2L
administration set; E-Z-EM) was placed in the rectum with
the patient in the left lateral decubitus position by a
dedicated CT technologist. After inflation of the retention
cuff, the cuff it was gently pulled back until its proximal
end rested on the anal sphincter. Colonic insufflation was
performed using carbon dioxide and an automated
insufflator (PROTOCO2L colon insufflator; E-Z-EM) under
the supervision of a radiologist. A supine scout view was
taken after the following suggestive signs of a fully
distended colon: intolerance of the patient, initial insuffla-
tion of approximately 2 to 2.5 L or a consistent rectal
pressure over 25 mmHg. Further insufflation was
performed when collapsed bowel segments were identi-
fied. After completion of the supine scan, the patient was
turned prone with a cushion placed under the lower chest
of the patient to decrease the compression of the abdomen.
A prone scout image was obtained. Further insufflation
was performed if the distention was deemed suboptimal.
CT scans were obtained using a 16-detector row scanner
(Somatom Sensation 16; Siemens, Erlangen, Germany)
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following parameter settings. The parameters were beam
collimation, 16  0.75 mm; reconstruction slice thickness,
1 mm; reconstruction interval, 0.7 mm; beam pitch, 1;
gantry rotation time, 0.5 seconds; table speed, 24 mm/sec;
field of view: to fit; 120 kV; 30 mAs.
Image Analysis
CTC images were reviewed by consensus of two experi-
enced radiologists (with an experience of more than 500
CTC cases and with an experience of approximately 50
CTC cases). Image review and analysis were performed
with the use of a commercial CTC system (Lucion; Infinitt,
Seoul, Korea).
Images were analyzed to evaluate the similarity of the
scanned datasets between group I and group II patients.
First, the entire colonic length was measured in each
patient. The colonic length was defined as the distance
from the anorectal junction to the cecal tip as measured on
the software-derived centerline of the colon. The center-
line distance was obtained both from the supine and the
prone datasets and then the two measurements were
averaged for each patient. Second, the degree of colonic
distention was assessed on a segmental basis (i.e. six
colonic segments of the rectum, sigmoid, descending,
transverse, ascending, and cecum (18)) according to the use
of a 4-point scale that Taylor et al. had previously used
(19): grade 1 (worst) to grade 4 (best). The definitions of
each grade have been described elsewhere (19).
Using both three-dimensional (3D) endoluminal fly-
through and two-dimensional (2D) review, every luminal
protrusion that was 6 mm or larger in its greatest linear
dimension was marked. Size measurement of the luminal
protrusions were performed on a 3D endoluminal view
(20). Images from both the supine and prone positions
were compared and luminal protrusions that showed an
apparent positional change between the two positions
were regarded to represent feces. Internal attenuation of
the luminal protrusions was examined both visually and by
the use of a region-of-interest (ROI) measurement. ROI
measurement was performed on 2D images at a window
width and level of 400 HU and 20 HU, respectively, to
avoid erroneous inclusion of colonic air within the ROI due
to the partial volume averaging effect (21). Luminal
protrusions that showed internal air-density or had attenu-
ation values higher than 200 HU were considered to
represent feces. Any luminal protrusions other than protru-
sions that met the aforementioned criteria for feces were
considered as polyp candidates, regardless of the morphol-
ogy. Those patients who were determined to have such
polyp candidates were referred for colonoscopy.
Evaluation of the degree of fecal tagging - The stool
pieces were visually categorized into completely tagged
(Fig. 1), incompletely tagged (Fig. 2), and untagged (Fig. 3)
according to the appearances at a window width and level
of 1,500 HU and -200 HU (the colon window setting),
respectively. Complete tagging (Fig. 1) was defined as
homogeneous high attenuation of the luminal protrusion
that appeared homogeneously “white” on the colon
window setting. Untagged feces (Fig. 3) represented stool
pieces that appeared “gray” and might be confused with
soft-tissue polyps in terms of attenuation at visual inspec-
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Fig. 1. Presence of completely tagged stool piece in 62-year-old man.
A. Transverse 2D CT colonography image of colon window setting (width, 1,500H; level, -200H) obtained with supine position shows 
44-mm completely tagged stool piece of homogeneous high attenuation (arrow) in rectum.
B. 3D endoluminal CT colonography image shows same stool piece (arrow) as in A.
ABtion. Incomplete tagging (Fig. 2) referred to the presence of
both “white” and “gray” portions within the stool pieces.
Attenuation values of the tagged feces were measured
using an ROI. For an incompletely tagged stool piece, the
ROI measurement was performed only in the tagged
portion and was performed only when the tagged portion
was at least a few millimeters in size to avoid erroneous
measurement due to the partial volume effect. An ROI was
drawn manually to encompass as much of each tagged
stool as possible. ROI measurements were performed on
2D images at a window width and level of 400 HU and 20
HU, respectively (21).
Evaluation of the degree of fluid tagging - The amount
of residual fluid in each colonic segment (the six colonic
segments) (18) were scored in the supine position accord-
ing to the ratio of the depth of the largest fluid pocket to
the anteroposterior (AP) luminal diameter in each colonic
segment (22). The scores were 1, no fluid; 2, < 25% AP
diameter; 3, 25 to 50% AP diameter; 4, > 50% AP
diameter. If fluid was present, the degree of fluid tagging
Kim et al.
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Fig. 2. Incompletely tagged stool piece in 55-year-old woman.
A. Transverse 2D CT colonography image of colon window setting (width, 1,500H; level, -200H) obtained with patient in supine position
shows 12-mm incompletely tagged stool piece (arrow) in descending colon. Only small fraction of stool piece is tagged (arrowhead).
B. 3D endoluminal CT colonography image shows same stool piece (arrow) as in A. 
AB
Fig. 3. Untagged stool piece in 58-year-old man.
A. Transverse 2D CT colonography image of colon window setting (width, 1,500H; level, -200H) obtained with patient in prone position
shows 14-mm untagged stool piece (arrow) in upper rectum, which shows similar attenuation to that of soft-tissue.
B. 3D endoluminal CT colonography image shows same stool piece (arrow) as in A.
ABwas scored as follows (13, 22): 1, untagged; 2, layered
tagging; and 3, homogeneously tagged. Layered tagging
indicates a mix of tagging densities with a denser
dependent layer and visibly less dense non-dependent
layer. The attenuation value of the tagged fluid was
measured by taking the average of three ROI measure-
ments (22). In case of layered tagging, the denser
dependent layer was measured.
Data and Statistical Analysis
The entire colonic length was compared between group I
and group II patients by use of the Student’s t-test. The
degree of colonic distention was compared between group
I and group II patients for each colonic segment in each
position by using the Wilcoxon rank sum test.
Efficacy of fecal tagging - The efficacy of fecal tagging
was analyzed on a per-lesion (per polypoid stool) basis and
a per-segment basis (per colonic segment according to the
six colonic segments (18)). For the per-lesion analysis, the
rates of complete tagging, all degrees of tagging and
untagging, defined as the numbers of completely-tagged,
tagged either completely or incompletely, and untagged
stool pieces 6 mm or larger, respectively, divided by the
total number of stool pieces 6 mm or larger were
calculated along with 95% confidence intervals (CIs). For
the per-segment analysis, the rates of complete tagging, all
degrees of tagging and untagging, defined as the numbers
of colonic segments with all stool pieces 6 mm or larger
that were completely tagged, with all stool pieces 6 mm or
larger that were tagged either completely or incompletely,
and with at least one stool piece 6 mm or larger that was
untagged, respectively, divided by the total number of
colonic segments with stool pieces 6 mm or larger, were
calculated along with 95% CIs. The rates were compared
between group I and group II patients. The attenuation
values of tagged stool pieces, including completely tagged
feces and the tagged portions of those incompletely tagged
feces, were compared between group I and group II
patients.
Efficacy of fluid tagging - The fluid amount scores were
compared between group I and group II patients. The fluid
tagging scores and the attenuation values of the tagged
fluid were compared between group I and group II patients
with residual fluid.
All statistical comparisons between group I and group II
were performed by the use of generalized estimating
equations unless specified otherwise in order to account for
data clustering. P values less than 0.05 were considered as
statistically significant. Statistical analysis was performed
with the use SPSS 15.0 software (SPSS, Chicago, IL).
RESULTS
Study Patients and Comparison of the CT colonography
Datasets between Group I and Group II
Five patients in group I and one patient in group II failed
to attend scheduled CTC appointments and therefore were
excluded from the study. The final study population
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Table 1. Comparison of Colonic Distention between Group I and Group II Patients
Rectum Sigmoid Descending Transverse Ascending Cecum Total
Supine Group I
No of seg* 10 10 10 10 10 10 60
Mean  SD
� 4.0 0.0 3.0 1.2 3.7 1.0 3.4 1.0 4.0 0.0 4.0 0.0 3.7 0.8
Group II
No of seg* 14 14 14 14 14 14 84
Mean  SD
� 3.9 0.3 3.4 1.1 3.5 1.1 3.6 1.0 4.0 0.0 4.0 0.0 3.7 0.8
P value 1.000 0.186 0.557 0.359 0.126 0.398 0.742
Prone Group I
No of seg* 10 10 10 10 10 10 60
Mean  SD
� 4.0 0.0 3.4 1.1 3.8 0.4 3.6 0.8 3.8 0.4 3.9 0.6 3.9 0.3
Group II
No of seg* 14 14 14 14 14 14 84
Mean  SD
� 4.0 0.0 3.6 0.9 3.5 0.9 3.9 0.4 3.9 0.3 4.0 0.2 4.0 0.0
P value 0.237 0.826 0.583 0.651 0.398 1.000 0.978
Note.─ Group I and group II patients used 40% w/v and 4.6% w/v barium suspensions, respectively, for fecal tagging.
*Number of colonic segments
�Mean distention grade standard deviation: grade 1 (worst) to grade 4 (best) (19)therefore consisted of 24 patients, including ten patients in
group I (five men and five women; mean age, 50 ± 8.4
years; age range, 29-58 years) and 14 patients in group II
(six men and eight women; mean age, 60.4 ± 15 years;
age range, 30-87 years). 
The entire colonic length ranged from 126.8 mm to
202.4 mm (165.8  23.2 mm) in group I and from 132.8
to 229.1 mm (172.3  26.5 mm) in group II, with no
demonstrable statistical significant difference (p = 0.551)
between the two groups.
The degree of distention in each colonic segment in each
position and comparisons between group I and group II
patients are summarized in Table 1. Overall, the colon was
well distended in both positions in all patients and there
was no significant difference between group I and group II
patients.
Efficacy of Fecal Tagging
In total, 79 luminal polypoid protrusions 6 mm or larger
were found on CTC, including 42 and 37 luminal protru-
sions in group I and group II, respectively. Two of the
luminal protrusions in two patients, both located in the
transverse colon, were considered as true polyps as seen
on CTC, whereas the other 77 luminal protrusions were
confirmed as stool pieces based on the movability on
positional change, presence of internal air and/or barium
tagging. The two patients subsequently underwent a
colonoscopy. The colonoscopy examination revealed no
lesion in one patient, confirming that the luminal protru-
sion was an adherent untagged stool piece. In the other
patient in group II, a 6 mm tubular adenoma was found
after the colonoscopy. Another patient underwent a
colonoscopy as per a request by the patient despite the
CTC negative result and was shown not to have any
colonic lesions. We excluded the 6 mm tubular adenoma,
and 42 and 36 polypoid stool pieces 6 mm or larger in
group I and group II, respectively, were finally included in
the analysis.
The results of the per-lesion and per-segment analyses of
fecal tagging efficacy are summarized in Table 2. For group
I, 22 of 42 (52.4%; 95% CI, 37.7-66.6%), 11 of 42
(26.2%; 95% CI, 15.2-41.2%) and nine of 42 (21.4%;
95% CI, 11.5-36.2%) stool pieces were completely
tagged, incompletely tagged, and untagged, respectively.
For group II, 28 of 36 (77.8%; 95% CI, 61.7-88.5%), six
of 36 (16.7%; 95% CI, 7.5-32.3%) and two of 36 (5.6%;
95% CI, 0.6-19.1%) stool pieces were completely tagged,
incompletely tagged, and untagged, respectively. The per-
lesion rates of complete tagging (p = 0.285) and all degrees
of tagging (p = 0.227) were not significantly different
between group I and group II.
Eighteen colonic segments in group I and 15 colonic
segments in group II had stool pieces 6 mm or larger,
whereas the other segments either had stool pieces 5 mm
or smaller or did not have residual stool. Per segment
analysis included the 18 and 15 colonic segments. The per-
segment rates of complete tagging (p = 0.171) and all
degrees of tagging (p = 0.219) were not significantly differ-
ent between group I and group II.
The mean HU of the tagged stool pieces was 817  293
HU (n = 30; range, 233-1,394 HU) for group I and 812 
325 HU (n = 33; range, 330-1,521 HU) for group II, with
no demonstrable statistical significant difference (p =
0.938).
Efficacy of Fluid Tagging
The number of colonic segments with each fluid score
was 48, 11, 1, and 0 for scores 1, 2, 3, and 4, respectively,
Kim et al.
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Table 2. Comparison of Fecal Tagging Efficacy between Group I and Group II Patients
Group I Group II P value
Per-lesion analysis
Total number of stool pieces 6 mm or larger 42 36
Number of completely tagged stool pieces 22 (52.4%) 28 (77.8%) 0.285
Number of tagged stool pieces (either completely or incompletely) 33 (78.6%) 34 (94.4%) 0.227
Number of untagged stool pieces 09 (21.4%) 2 (5.6%)
Per-segment analysis
Total number of colonic segments with stool pieces 6 mm or larger 18 15
Number of completely tagged segments* 06 (33.3%) 09 (60%)0. 0.171
Number of tagged segments (either completely or incompletely)
� 12 (66.7%) 13 (86.7%) 0.219
Number of untagged segments
� 06 (33.3%) 02 (13.3%)
Note.─ Group I and group II patients used 40% w/v and 4.6% w/v barium suspensions, respectively, for fecal tagging.
*Colonic segments with all stool pieces 6 mm or larger that were completely tagged.
�Colonic segments with all stool pieces 6 mm or larger that were tagged either completely or incompletely.
�Colonic segments with at least one stool piece 6 mm or larger that were untagged.in group I and 56, 22, 4, and 2, respectively, in group II.
The vast majority of colonic segments (98.3% [59 of 60] in
group I and 92.9% [78 of 84] in group II) either did not
have luminal fluid or had only small amount of fluid (fluid
scores 1 or 2). There was no statistically significant differ-
ence in the fluid amount between group I and group II (p =
0.156). The analysis of the degree of fluid tagging included
the 12 segments and 28 segments with residual fluid in
group I and group II, respectively.
For group I, 8 of 12 (66.7%; 95% CI, 38.8-86.5%), one
of 12 (8.3%; 95% CI, less than 0.01-37.5%) and three of
12 (25%; 95% CI, 8.3-53.9%) colonic segments showed
untagged fluid (score 1), layered tagging (score 2) and
homogeneously tagged fluid (score 3), respectively. For
group II, 14 of 28 (50%; 95% CI, 32.6-67.4%), one of 28
(3.6%; 95% CI, less than 0.01-19.2%) and 13 of 28
(46.4%; 95% CI, 29.5-64.2%) colonic segments showed
untagged fluid (score 1), layered tagging (score 2) and
homogeneously tagged fluid (score 3), respectively. The
average fluid tagging score was 1.6 0.9 in group I and
2.0 1.0 in group II; the difference was not statistically
significant (p = 0.387). The mean attenuation of tagged
fluid was 647 307 HU (range, 267-913 HU) and 547
139 HU (range, 360-856 HU) for group I and group II,
respectively, indicating no statistically significant difference
(p = 0.547).
DISCUSSION
We evaluated the efficacy of barium-based fecal tagging
for CTC and compared the tagging efficacy between the
use of high-density (40% w/v) and low-density (4.6% w/v)
barium suspensions in a population from Korea. Our study
showed that the tagging efficacy of both the 40% w/v and
the 4.6% w/v barium suspensions were moderate, showing
52% (22 of 42) and 78% (28 of 36) rates of complete
tagging, respectively, in terms of per-lesion analysis.
One previous study performed in a Western population
that used the same 40% w/v barium-based tagging suspen-
sion reported a 76% (154 of 203) rate of complete tagging
in terms of per-segment analysis (13). Compared to the
previous study (13), the per-segment rates of complete
fecal tagging in our study, 33% (6 of 18) and 60% (9 of
15) with the 40% w/v and 4.6% w/v bariums suspensions,
respectively, appears to be lower and may suggest a lower
efficacy of barium-based fecal tagging in Korean patients.
The different results between the previous study (13) and
the present study may be due to a multitude of factors
including the difference in the diet consumed the day
before the CTC; i.e. a structured low-residue diet was used
in the previous study (13) versus rice porridge in the
present study. Unfortunately, due to some differences in
the study methods, it is difficult to estimate clearly and to
understand the difference in tagging efficacy between the
two studies. The results of per-segment analysis should be
interpreted carefully as a low rate in the per-segment
analysis may not necessarily mean a low tagging efficacy.
In the per-segment analysis, when multiple stool pieces are
present in each colonic segment, the tagging efficacy is
calculated as very low as long as at least one of the
multiple stool pieces is poorly tagged, regardless of the
number of well-tagged stool pieces. Therefore, the tagging
efficacy can be underestimated. Moreover, interpretation
of CTC is not performed on a segmental basis but the
interpretation consists of the characterization of each and
of every luminal protrusion into a true polyp or residual
feces; thus, a per-lesion analysis would be more clinically
relevant than a per-segment analysis. This was the reason
why we analyzed the data both on a per-lesion and on a
per-segment basis. Therefore, it is difficult to compare
clearly the present results with the findings of the previous
study (13). It is even more difficult to know the difference
between our results and those of some other previous
studies (2, 8) as those studies analyzed the tagging efficacy
mostly on a per-segment basis and did not provide the
exact rates of untagged stool (2, 8).
Regardless of whether or not barium-based fecal tagging
is less effective in a population of Korean patients as
compared to Western patients, what is clear from our
study is that barium-based tagging with both the use of the
40% w/v and 4.6% w/v preparations requires further
improvement. Although barium-based fecal tagging has
been widely accepted for CTC, the finding that the method
is not always ideal for fecal tagging has been consistently
observed in previously studies (2, 6-8, 10-13) as well as in
the present study. Imperfect fecal tagging with the remain-
ing untagged stool pieces does not always pose a substan-
tial diagnostic problem as untagged stool pieces can be
clearly differentiated from true polyps by mobility,
presence of internal air and morphology in many cases, as
demonstrated in our study and also in previous studies (2,
8, 13). Nevertheless, there is no doubt that better quality
of fecal tagging will further improve the interpretation of
CTC. First, false-positive diagnoses can be reduced with a
better degree of fecal tagging as demonstrated by the
occurrence of one false-positive diagnosis in our study.
Second, visualization of polyps covered with residual feces
will be improved, resulting in better detection of such
lesions. Third, straightforward differentiation of true
polyps from tagged stools will be possible based on attenu-
ation alone, which will substantially reduce the tedious and
time-consuming matching of polyp candidates between the
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the positional change. Fourth, it has become easier and
more effective to incorporate advanced interpretive
software tools such as electronic cleansing, volume render-
ing with attenuation-dependent discriminative color-coding
of tagged stool or computer-aided detection in the
interpretation of CTC as these software tools are not
effective with incompletely or inhomogeneously tagged
feces (23-26).
Our study showed a tendency towards better tagging
with the use of the 4.6% w/v barium suspension than with
the 40% w/v barium suspension; therefore, a study of a
larger sample size might be able to confirm the superior
efficacy of one tagging agent to the other, although this is
conjecture. The findings of the present study cannot
provide clear information regarding this issue, which is a
limitation. However, we believe that it would be more
important to understand the limitations of the use of both
barium-based tagging agents in a population of Korean
patients, which our study has clearly shown, and to
contrive ways to improve the tagging efficacy rather than
merely to determine which agent yields better fecal
tagging.
As one way to improve fecal tagging efficacy, a combina-
tion of a barium suspension with a water-soluble iodinated
agent such as gastrografin may be worthy of further
investigation. Barium-based tagging methods are also
generally ineffective for fluid tagging as demonstrated in
the present study; the majority of colonic segments with
residual colonic fluid (75% [9 of 12] and 53.6% [15/28] in
group I and group II, respectively) showed either untagged
fluid or layered tagging. Therefore, the use of gastrografin
will improve fluid tagging as well. As gastrografin has a
mildly cathartic effect (27), a smaller amount of fecal
residue is also expected with the use of gastrografin. Given
that a large amount of residual tagged fecal matter, even
though well-tagged, may sometimes ironically make the
interpretation of CTC more difficult (7, 16), some
reduction in the amount of residual feces with the use of
gastrografin could be an additional advantage. A limitation
of the use of gastrografin is that it may potentially decrease
patient compliance due to a bitter taste. As the ultimate
goal of fecal tagging is not only to improve the diagnostic
accuracy and the reading efficiency but also to improve
patient compliance to participate in the examination,
further studies are required to determine when to use and
how to use gastrografin in conjunction with barium-based
tagging agents.
Attenuation of the tagged fecal matter is another factor
that determines the effectiveness of fecal tagging as weakly
tagged feces may have a potential to mimic contrast-
enhanced polyps or vice versa (16). Fortunately, this
potential pitfall is most likely a very rare phenomenon for
several reasons. Firstly, CTC for colorectal cancer screen-
ing, which is the foremost indication for the application of
CTC, is typically performed without the requirement for
intravenous contrast injection. Second, even with the use
of intravenous contrast enhancement, as patients are
scanned twice in the supine and prone positions, one scan
can be obtained without intravenous contrast that allows
for the opportunity to confirm the presence of contrast-
enhanced lesions. Third, contrast-enhanced colorectal
polyps are generally seen with a much lower attenuation
than barium-tagged fecal matter (21). Our study results
also showed that the attenuation of tagged stool with both
the use of 40% w/v and 4.6% w/v barium suspensions was
much higher than the attenuation values of contrast-
enhanced polyps as previously reported in the clinical
literature (21). Nevertheless, the lowest attenuation value
of tagged feces was as low as 233 HU in our study (with
the use of the 40% w/v barium suspension), alerting the
necessity of some improvement for consistent achievement
of high attenuation. Combined use of barium and an
iodinated agent may be useful in this regard as well.
This study has limitations. First, the study was a prelimi-
nary study with a small sample size and without random-
ization of patients. Therefore, the comparison between the
two tagging methods was not conclusive. Randomization
was not used as it was considered most likely ineffective or
meaningless for a small number of patients where a
multitude of potential factors may affect bowel habit and
the amount of residual feces. Second, colonoscopy was
performed only in a subset of the patients. Even though
endoscopic confirmation was not available in many
patients, we believe that our specified radiographic criteria
allowed for unequivocal identification of residual feces and
our method was sound in terms of investigating the
efficacy of fecal tagging. Third, we used one method of
purgative bowel cleaning. The tagging efficacy may vary
with the use of different bowel cleansing methods.
Moreover, as one of the major advantages of fecal tagging
is the reduced need for purgative bowel cleansing, investi-
gation of the tagging efficacy in a reduced-cathartic or
cathartic-free environment may be worthy of further
investigation.
In conclusion, barium-based fecal tagging using both the
40% w/v and the 4.6% w/v barium suspensions showed
moderate tagging efficacy. The preliminary comparison did
not demonstrate a statistically significant difference in the
tagging efficacy between the two tagging agents despite the
tendency toward better tagging with the use of the 4.6%
w/v barium suspension.
Kim et al.
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